文献速递心胸血管麻醉术前评估与围术期医学

纤维蛋白原/白蛋白比值与体外循环成人心脏手术结局

Fibrinogen/Albumin Ratio and Outcome in Adult Cardiac Surgery With Cardiopulmonary Bypass.
PubMed 文献 · Anesth Analg · 2025-11-24

这项回顾性研究纳入836例体外循环下成人心脏手术患者,评估纤维蛋白原/白蛋白比值(F/A ratio)对主要并发症的预测价值。F/A比值单变量与主要并发症相关(OR 1.025,95%CI 1.061-1.091,P=.004),但单独预测区分度差(AUC 0.606);基于EuroSCORE II的多变量模型AUC显著更优(0.731,P<.001),加入F/A比值未显著改善(AUC 0.730)。结论认为F/A比值单独预测价值差,纳入现有风险模型无额外价值。

要点

  • F/A比值单独预测主要并发症区分度差(AUC 0.606)。
  • EuroSCORE II模型AUC 0.731显著优于单独F/A比值。
  • 将F/A比值加入EuroSCORE II模型未改善区分度、校准或风险重分类。

核心结论

  • F/A比值单独对体外循环成人心脏手术主要并发症的预测性能差,纳入现有风险模型无额外价值。
  • 在体外循环心脏手术背景下未证实F/A比值在其他场景(如非体外循环心脏手术)中的有用性。

研究设计与样本

  • 回顾性研究,纳入836例接受体外循环下心脏手术的成人患者,计算F/A比值并收集术前因素(人口学、合并症、手术细节及EuroSCORE II)。

主要发现

  • F/A比值单变量与主要并发症相关(OR 1.025,95%CI 1.061-1.091,P=.004),但ROC曲线下面积(AUC)为0.606。
  • 基于EuroSCORE II的多变量风险模型AUC为0.731,显著优于单独F/A比值(P<.001)。
  • 将F/A比值纳入EuroSCORE II模型后AUC为0.730,未见显著改善。
  • 含与不含F/A比值的模型对主要并发症预测的校准相似,且含F/A比值模型未显著改变患者风险分类。

关键数值与推荐

  • 主要并发症定义:因任何心脏原因再次手术、卒中、需肾脏替代治疗的急性肾损伤、深部胸骨伤口感染、延长机械通气中的1项或以上。

临床怎么用

  • 在体外循环成人心脏手术风险预测中,不建议将F/A比值单独或加入EuroSCORE II模型用于主要并发症风险评估。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibrinogen/albumin ratio (F/A ratio) has been proposed as a prognostic factor for different outcomes in different clinical settings, including cardiovascular interventions. However, few studies address the F/A ratio as a possible predictor of postoperative outcome in adult cardiac surgery with cardiopulmonary bypass (CPB). The hypothesis of the present study is that by including the F/A ratio in the existing risk models for major morbidity after adult cardiac surgery may result in better discrimination, calibration, and risk reclassification of the model. METHODS: This is a retrospective study including 836 adult patients who underwent cardiac surgery with CPB. Every patient received an F/A ratio calculation, and other preoperative factors were collected (demographics, comorbidities, operation details, and EuroSCORE II). The primary outcome measure was major morbidity, defined as 1 or more of the following: surgical revision for any cardiac reason; stroke; acute kidney injury requiring renal replacement therapy; deep sternal wound infection; prolonged mechanical ventilation. The F/A ratio alone and EuroSCORE II-based predictive models with or without the F/A ratio were tested for major morbidity predictive properties. RESULTS: F/A ratio was univariately associated with major morbidity (odds ratio 1.025, 95% confidence interval 1.061-1.091, P = .004), but carried a poor discrimination for major morbidity with an area under the curve (AUC) for receiver operating characteristics (ROC) analysis of 0.606. A multivariable risk model based on the EuroSCORE II yielded a significantly ( P < .001) better AUC (0.731); the inclusion of F/A ratio within this model did not significantly improve this value, which remained at 0.730. The models with or without F/A ratio had similar calibration for major morbidity prediction, and the model inclusive of F/A ratio did not significantly change the risk classification of the patients. CONCLUSIONS: The F/A ratio alone has poor predictive properties for major morbidity, and there is no added value in including the F/A ratio into the existing risk models. In the setting of adult cardiac surgery with CPB, we did not confirm the usefulness of the F/A ratio described in other settings, such as cardiac surgery without CPB. This may be due to both the consumption and sequestration of these proteins during CPB.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Casalino S, Anguissola M, Barbaria A, et al. Fibrinogen/Albumin Ratio and Outcome in Adult Cardiac Surgery With Cardiopulmonary Bypass. Anesth Analg. 2025. PMID: 42202219. doi:10.1213/ANE.0000000000007845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。